My clinic uses Thorne, Sarbaziha shares
Two of the three hormones retatrutide mimics are already available in FDA-approved weight loss medications, so the patient who was granted early access likely sought benefits primarily stemming from the third hormone, which activates the livers glucagon receptors
Tirzepatide mimics the action of two incretin hormonesglucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP)to enhance insulin secretion in response to meals, suppress glucagon release, and slow gastric emptying, leading to improved glycemic control and potential weight loss
What is known comes from animal studies and anecdotal reports within research and nootropic circles
PCOS patients with a personal or family history of thyroid cancer, medullary carcinoma, or pancreatitis should discuss tirzepatide with their provider beforehand